Menu Search
Equities

Orthofix Medical Inc

OM2:DEU

Orthofix Medical Inc

Actions
  • Price (EUR)17.60
  • Today's Change0.10 / 0.57%
  • Shares traded0.00
  • 1 Year change+82.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Orthofix Medical Inc's net income fell 666.60% from a loss of 19.75m to a larger loss of 151.40m despite revenues that grew 62.06% from 460.71m to 746.64m. An increase in the cost of goods sold as a percentage of sales from 26.82% to 34.87% was a component in the falling net income despite rising revenues.
Gross margin68.05%
Net profit margin-15.18%
Operating margin-11.66%
Return on assets-13.42%
Return on equity-20.86%
Return on investment-16.31%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Orthofix Medical Inc fell by 12.94m. Cash Flow from Financing totalled 65.32m or 8.75% of revenues. In addition the company used 45.75m for operations while cash used for investing totalled 33.13m.
Cash flow per share-1.61
Price/Cash flow per share--
Book value per share13.76
Tangible book value per share5.93
More ▼

Balance sheet in USDView more

Orthofix Medical Inc has a Debt to Total Capital ratio of 20.69%, a higher figure than the previous year's 14.41%.
Current ratio2.39
Quick ratio1.11
Total debt/total equity0.2609
Total debt/total capital0.2069
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.